Program Affiliation Cont... ECHO Trial
Date
Title
Status
All
Completed
Current
Program Affiliation
All
HPTN
MTCT-Plus
COVID
MCAP
UTAP
Global TA
PHIA
QICIP
TRACE
CQUIN
GNCBP
OpCon
OPTIMIZE
Project Location
All
Mozambique
Angola
Burundi
Liberia
Philippines
Brazil
Guatemala
Georgia
Haiti
China
Cameroon
Côte d’Ivoire
Democratic Republic of the Congo
Lesotho
Kazakhstan
Kyrgyzstan
Kenya
Namibia
Ethiopia
Nigeria
Rwanda
Tajikistan
Malawi
Sierra Leone
Zimbabwe
Tanzania
Eswatini
South Sudan
Mali
South Africa
Uganda
Zambia
United States
Ukraine
Myanmar
Central Asia
november
Project Details
ICAP supported the Ministry of Health to implement the ECHO Study, a multi-country, open label, randomized clinical trial that assessed the effect of three highly effective, reversible methods of contraception—depot
Project Details
ICAP supported the Ministry of Health to implement the ECHO Study, a multi-country, open label, randomized clinical trial that assessed the effect of three highly effective, reversible methods of contraception—depot medroxyprogesterone acetate, the levonorgestrel implant, and the copper intrauterine device—on the risk of HIV acquisition in women in sub-Saharan Africa. This study is Swaziland’s first experience with an interventional randomized clinical trial and is being conducted by ICAP in collaboration with the Family Life Association of Swaziland, a local sexual and reproductive health service provider. (funded by consortium of donors via FHI360)
For more information, visit http://echo-consortium.com/
ECHO trial implementation is complete; dissemination activities are ongoing
december
Project Details
ICAP supported the Ministry of Health to implement the ECHO Study, a multi-country, open label, randomized clinical trial that assessed the effect of three highly effective, reversible methods of contraception—depot
Project Details
ICAP supported the Ministry of Health to implement the ECHO Study, a multi-country, open label, randomized clinical trial that assessed the effect of three highly effective, reversible methods of contraception—depot medroxyprogesterone acetate, the levonorgestrel implant, and the copper intrauterine device—on the risk of HIV acquisition in women in sub-Saharan Africa. This study is Swaziland’s first experience with an interventional randomized clinical trial and is being conducted by ICAP in collaboration with the Family Life Association of Swaziland, a local sexual and reproductive health service provider. (funded by consortium of donors via FHI360)
For more information, visit http://echo-consortium.com/
ECHO trial implementation is complete; dissemination activities are ongoing
january
Project Details
ICAP supported the Ministry of Health to implement the ECHO Study, a multi-country, open label, randomized clinical trial that assessed the effect of three highly effective, reversible methods of contraception—depot
Project Details
ICAP supported the Ministry of Health to implement the ECHO Study, a multi-country, open label, randomized clinical trial that assessed the effect of three highly effective, reversible methods of contraception—depot medroxyprogesterone acetate, the levonorgestrel implant, and the copper intrauterine device—on the risk of HIV acquisition in women in sub-Saharan Africa. This study is Swaziland’s first experience with an interventional randomized clinical trial and is being conducted by ICAP in collaboration with the Family Life Association of Swaziland, a local sexual and reproductive health service provider. (funded by consortium of donors via FHI360)
For more information, visit http://echo-consortium.com/
ECHO trial implementation is complete; dissemination activities are ongoing
february
Project Details
ICAP supported the Ministry of Health to implement the ECHO Study, a multi-country, open label, randomized clinical trial that assessed the effect of three highly effective, reversible methods of contraception—depot
Project Details
ICAP supported the Ministry of Health to implement the ECHO Study, a multi-country, open label, randomized clinical trial that assessed the effect of three highly effective, reversible methods of contraception—depot medroxyprogesterone acetate, the levonorgestrel implant, and the copper intrauterine device—on the risk of HIV acquisition in women in sub-Saharan Africa. This study is Swaziland’s first experience with an interventional randomized clinical trial and is being conducted by ICAP in collaboration with the Family Life Association of Swaziland, a local sexual and reproductive health service provider. (funded by consortium of donors via FHI360)
For more information, visit http://echo-consortium.com/
ECHO trial implementation is complete; dissemination activities are ongoing
march
Project Details
ICAP supported the Ministry of Health to implement the ECHO Study, a multi-country, open label, randomized clinical trial that assessed the effect of three highly effective, reversible methods of contraception—depot
Project Details
ICAP supported the Ministry of Health to implement the ECHO Study, a multi-country, open label, randomized clinical trial that assessed the effect of three highly effective, reversible methods of contraception—depot medroxyprogesterone acetate, the levonorgestrel implant, and the copper intrauterine device—on the risk of HIV acquisition in women in sub-Saharan Africa. This study is Swaziland’s first experience with an interventional randomized clinical trial and is being conducted by ICAP in collaboration with the Family Life Association of Swaziland, a local sexual and reproductive health service provider. (funded by consortium of donors via FHI360)
For more information, visit http://echo-consortium.com/
ECHO trial implementation is complete; dissemination activities are ongoing